Citations

Clear

7552 citation(s) found for "Ho, Matthew".

Delayed Patch-Test Reading After 5 Days: An Update From the Mayo Clinic Contact Dermatitis Group
Chaudhry, Hafsa, Drage, Lisa A., Hall, Matthew R., Killian, Jill M. , Prakash, Amy V., Yiannias, James A. , Davis, Mark D.P. , Cantwell, Hafsa M. , Chaudhry, Hafsa M, el‐Azhary, Rokea A.

Mayo Clinic

Dermatitis® | July 18, 2017 | Volume: 28 | Issue: 4 | Pages: 253-260

10.1097/der.0000000000000297 | PMID 28719473 Get It

Background Patch-test readings after day 5 have previously been used to identify delayed reactions to metals and topical antibiotics. Objective The aims of this study were to identify allergens for which late readings (beyond day 5) would be most valuable and to compare our results with our previous study on delayed patch-test readings. Methods This was a retrospective study of 298 patients who underwent metal and corticosteroid series patch testing from January 1, 2007, through December 31, 2013. Patch-test readings were conducted on days 3 and 5 and at least once sometime between days 7 and 14. All reactions were examined at each reading. Conclusions These results were concordant with our previous findings that additional readings after day 7 are particularly useful for identifying reactions to metals (gold, cobalt, beryllium, palladium), specific preservatives (dodecyl gallate, propolis), and the topical antibiotic neomycin. New delayed reactions to bacitracin, p -phenylenediamine, and topical corticosteroids were not seen in this cohort.
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab
Malecek, Mary‐Kate , Petrich, Adam M., Rozell, Shaina, Chu, Benjamin A., Trifilio, Steven , Galanina, Natalie , Maurer, Matthew J. , Farooq, Umar , Link, Brian K. , Nowakowski, Grzegorz S. , Nabhan, Chadi , Ayed, Ayed O. , Maurer, Matthew , Farooq, Umar , Ayed, Ayed , Link, Brian K

Mayo Clinic

American Journal of Hematology | July 18, 2017 | Volume: 92 | Issue: 11 | Pages: 1156-1162

10.1002/ajh.24864 | PMID 28719025 Get It

AbstractBackgroundCentral nervous system (CNS) relapse in non‐Hodgkin lymphoma (NHL) is a rare but serious complication that carries a poor prognosis. The use of infusional etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (EPOCH‐R) for frontline treatment of diffuse large B cell lymphoma (DLBCL) is increasing, though little is known about incidence of and risk factors for CNS relapse with this regimenPatients and methodsWe completed a chart review of patients with NHL who received EPOCH‐R as front line therapy. Data obtained included baseline and treatment characteristics including if patients received CNS directed therapy. We measured overall survival (OS), progression free survival (PFS), and progression to CNS involvement.ResultsWe identified 223 patients who met the inclusion criteria, 72% had DLBCL. Of all the patients, 5.8% experienced CNS relapse, and 38.6% were treated with CNS prophylaxis. There was no difference in rate of CNS relapse, OS, or PFS between patients who had and had not received CNS prophylaxis. Patients whose serum lactate dehydrogenase was greater than twice the upper limit of normal at diagnosis and those with extranodal disease were significantly more likely to have CNS relapse (P = .0247 and 0.022, respectively) than their counterparts.ConclusionsThe rate of CNS relapse in this patient population approaches 6%, not significantly different from reports on those receiving R‐CHOP. The results of this study suggest that CNS prophylaxis might be more selectively used among patients treated with EPOCH‐R with certain high‐risk features.
Variability of performance status assessment between patients with hematologic malignancies and their physicians
Leal, Alexis D. , Allmer, Cristine, Link, Brian K. , Thompson, Carrie A. , Maurer, Matthew J. , Shanafelt, Tait D. , Cerhan, James R. , Link, Brian K

Mayo Clinic

Leukemia & Lymphoma | July 18, 2017 | Volume: 59 | Issue: 3 | Pages: 695-701

10.1080/10428194.2017.1347930 | PMID 28718335 Get It

Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids
Laughlin-Tommaso, S.K., Hesley, Gina K. , Hopkins, Matthew R. , Brandt, Kathleen R. , Zhu, Yunxiao , Stewart, Elizabeth A.

Mayo Clinic

International Journal of Gynecology & Obstetrics | July 17, 2017 | Volume: 139 | Issue: 2 | Pages: 143-148

10.1002/ijgo.12266 | PMID 28715088 Get It

AbstractObjectiveTo determine the reproducibility of classifying uterine fibroids using the 2011 International Federation of Gynecology and Obstetrics (FIGO) staging system.MethodsThe present retrospective cohort study included patients presenting for the treatment of symptomatic uterine fibroids at the Gynecology Fibroid Clinic at Mayo Clinic, Rochester, USA, between April 1, 2013 and April 1, 2014. Magnetic resonance imaging of fibroid uteri was performed and the images were independently reviewed by two academic gynecologists and two radiologists specializing in fibroid care. Fibroid classifications assigned by each physician were compared and the significance of the variations was graded by whether they would affect surgical planning.ResultsThere were 42 fibroids from 23 patients; only 6 (14%) fibroids had unanimous classification agreement. The majority (36 [86%]) had at least two unique answers and 4 (10%) fibroids had four unique classifications. Variations in classification were not associated with physician specialty. More than one‐third of the classification discrepancies would have impacted surgical planning.ConclusionFIGO fibroid classification was not consistent among four fibroid specialists. The variation was clinically significant for 36% of the fibroids. Additional validation of the FIGO fibroid classification system is needed.
An Introduction to the Blockchain and Its Implications for Libraries and Medicine
Hoy, Matthew B.

Mayo Clinic

Medical Reference Services Quarterly | July 17, 2017 | Volume: 36 | Issue: 3 | Pages: 273-279

10.1080/02763869.2017.1332261 | PMID 28714815 Get It

Outcomes of Primary Reverse Shoulder Arthroplasty for Dislocation Arthropathy
Sperling, John W. , Cofield, Robert H. , Chalmers, Brian P. , Wagner, Eric R. , Houdek, Matthew T. , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Shoulder and Elbow Arthroplasty | July 14, 2017 | Volume: 1 | Issue: No issue available | Pages: No page available

10.1177/2471549217717165 Get It

Background Proper soft tissue balance is paramount to maintaining stability and a functional arc of motion in shoulder arthroplasty but is impaired in patients with prior glenohumeral (GH) dislocations. The purpose of this study was to determine the clinical outcomes, revisions, and complications of reverse shoulder arthroplasty (RSA) in patients with a history of glenohumeral dislocation. Methods Twenty-four patients with a history of GH dislocations that developed arthropathy underwent primary RSA from 2007 to 2013 were retrospectively reviewed. Mean follow-up was 3.3 years (2–7 years). Mean age was 70 years. Eight patients (33%) and 7 patients (29%) had complete or partial subscapularis deficiency, respectively. Results Twenty-two patients (92%) had little to no pain at final follow-up. Mean shoulder elevation improved from 48° to 120° ( P < .001) and mean external rotation increased from 13.2° to 48° ( P < .001). There were trends toward less complete pain relief and poorer motion in those with complete subscapularis deficiency. None of the patients experienced a postoperative dislocation or evidence of glenoid loosening at final radiographic follow-up, but 1 patient (4.2%) underwent early revision to a hemiarthroplasty for glenoid loosening. Conclusion RSA provides patients with prior glenohumeral dislocations a stable, pain-free arc of motion. Postoperative instability was not identified as a major failure mode at short-term follow-up. Complete subscapularis deficiency is a risk factor for poorer clinical outcome.
Long-term rates of mitochondrial protein synthesis are increased in mouse skeletal muscle with high-fat feeding regardless of insulin-sensitizing treatment
Newsom, Sean A. , Miller, Benjamin F. , Hamilton, Karyn L. , Ehrlicher, Sarah E., Stierwalt, Harrison D. , Robinson, Matthew M.

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | July 11, 2017 | Volume: 313 | Issue: 5 | Pages: E552-E562

10.1152/ajpendo.00144.2017 | PMID 28698283 Get It

Skeletal muscle mitochondrial protein synthesis is regulated in part by insulin. The development of insulin resistance with diet-induced obesity may therefore contribute to impairments to protein synthesis and decreased mitochondrial respiration. Yet the impact of diet-induced obesity and insulin resistance on mitochondrial energetics is controversial, with reports varying from decreases to increases in mitochondrial respiration. We investigated the impact of changes in insulin sensitivity on long-term rates of mitochondrial protein synthesis as a mechanism for changes to mitochondrial respiration in skeletal muscle. Insulin resistance was induced in C57BL/6J mice using 4 wk of a high-fat compared with a low-fat diet. For 8 additional weeks, diets were enriched with pioglitazone to restore insulin sensitivity compared with nonenriched control low-fat or high-fat diets. Skeletal muscle mitochondrial protein synthesis was measured using deuterium oxide labeling during weeks 10–12. High-resolution respirometry was performed using palmitoyl-l-carnitine, glutamate+malate, and glutamate+malate+succinate as substrates for mitochondria isolated from quadriceps. Mitochondrial protein synthesis and palmitoyl- l-carnitine oxidation were increased in mice consuming a high-fat diet, regardless of differences in insulin sensitivity with pioglitazone treatment. There was no effect of diet or pioglitazone treatment on ADP-stimulated respiration or H2O2 emission using glutamate+malate or glutamate+malate+succinate. The results demonstrate no impairments to mitochondrial protein synthesis or respiration following induction of insulin resistance. Instead, mitochondrial protein synthesis was increased with a high-fat diet and may contribute to remodeling of the mitochondria to increase lipid oxidation capacity. Mitochondrial adaptations with a high-fat diet appear driven by nutrient availability, not intrinsic defects that contribute to insulin resistance.
Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer
Stroup, Sean P. , Moreira, Daniel M. , Chen, Zinan, Howard, Lauren E. , Berger, Jonathan , Amling, Christopher L. , Freedland, Stephen J. , Terris, Martha K. , Aronson, William J. , Cooperberg, Matthew R , Kane, Christopher J. , Howard, Lauren E

Mayo Clinic

Journal of Urology | July 11, 2017 | Volume: 198 | Issue: 6 | Pages: 1309-1315

10.1016/j.juro.2017.07.009 | PMID 28709888 Get It

United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for Calcitonin
Kahaly, George J. , Davis, Thomas E., Diana, Tanja, Feldkamp, Joachim , Karger, Stefan, Lupo, Mark A. , Raue, Friedhelm , Ringel, Matthew D. , Sipos, Jennifer A. , Kratzsch, Jüergen, Algeciras‐Schimnich, Alicia , König, J. , Ringel, Matthew D

Mayo Clinic

Clinical Chemistry | July 7, 2017 | Volume: 63 | Issue: 9 | Pages: 1489-1496

10.1373/clinchem.2016.270009 | PMID 28687633 Get It

Abstract BACKGROUND The objective of this study is the validation and proof of clinical relevance of a novel electrochemiluminescence immunoassay (ECLIA) for the determination of serum calcitonin (CT) in patients with medullary thyroid carcinoma (MTC) and in different diseases of the thyroid and of calcium homeostasis. METHODS This was a multicenter prospective study on basal serum CT concentrations performed in 9 US and European referral institutions. In addition, stimulated CT concentrations were measured in 50 healthy volunteers after intravenous calcium administration (2.5 mg/kg bodyweight). RESULTS In total, 1929 patients and healthy controls were included. Limits of blank, detection, and quantification for the ECLIA were 0.3, 0.5, and 1 ng/L, respectively. Highest intra- and interassay coefficients of variation were 7.4% (CT concentration, 0.8 ng/L) and 7.0% (1.1 ng/L), respectively. Medians (interval) of serum CT concentrations in 783 healthy controls were 0.8 ng/L (&lt;0.5–12.7) and 3 ng/L (&lt;0.5–18) for females and males, respectively (97.5th percentile, 6.8 and 11.6 ng/L, respectively). Diagnostic sensitivity and specificity were 100%/97.1% and 96.2%/96.4%, for female/males, respectively. Patients (male/female) with primary hyperparathyroidism, renal failure, and neuroendocrine tumors showed CT concentrations &gt;97.5th percentile in 33%/4.7%, 18.5%/10%, and 8.3%/12%, females/males, respectively. Peak serum CT concentrations were reached 2 min after calcium administration (161.7 and 111.8 ng/L in males and females, respectively; P &lt; 0.001). CONCLUSIONS Excellent analytical performance, low interindividual variability, and low impact of confounders for increased CT concentrations in non-MTC patients indicate that the investigated assay has appropriate clinical utility. Calcium-stimulated CT results suggest good test applicability owing to low interindividual variability.
Trapping and Deflation to Clip a Posterior Communicating Artery Aneurysm: A 2-Dimensional Surgical Video Illustration
Aoun, Rami James N. , Sattur, Mithun G. , Welz, Matthew E., Bendok, Bernard R.

Mayo Clinic

Operative Neurosurgery | July 7, 2017 | Volume: 14 | Issue: 2 | Pages: 201-201

10.1093/ons/opx076 | PMID 28973301 Get It